Conjugate of PAMAM Dendrimer, Doxorubicin and Monoclonal Antibody—Trastuzumab: The New Approach of a Well-Known Strategy

Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer

(2016) Hitesh Kulhari et al.   Scientific Reports

Targeted delivery of polyamidoamine-paclitaxel conjugate functionalized with anti-human epidermal growth factor receptor 2 trastuzumab

(2015) Pengkai Ma et al.   International Journal of Nanomedicine

Nanoparticles as drug delivery systems

(2014) Agnieszka Z. Wilczewska et al.   Pharmacological Reports

Targeted delivery of doxorubicin: Drug delivery system based on PAMAM dendrimers

(2013) N. G. Yabbarov et al.   BIOCHEMISTRY-MOSCOW

Dendrimer as nanocarrier for drug delivery

(2013) Prashant Kesharwani et al.   PROGRESS IN POLYMER SCIENCE

Targeting of nanoparticles in cancer

(2011) Meghna Talekar et al.   ANTI-CANCER DRUGS

Tumor-Targeted Drug Delivery with Aptamers

(2011) Y. Zhang et al.   CURRENT MEDICINAL CHEMISTRY

Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications

(2010) Anupa R. Menjoge et al.   DRUG DISCOVERY TODAY

Anionic Amino Acid Dendrimer−Trastuzumab Conjugates for Specific Internalization in HER2-Positive Cancer Cells

(2010) Takuya Miyano et al.   MOLECULAR PHARMACEUTICS

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

(2009) Saijie Zhu et al.   PHARMACEUTICAL RESEARCH

Active targeting schemes for nanoparticle systems in cancer therapeutics

(2008) James D. Byrne et al.   ADVANCED DRUG DELIVERY REVIEWS

HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER2 mAb

(2008) Rameshwer Shukla et al.   NANOTECHNOLOGY